A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Conditions: COVID-19; SARS-CoV-2 Infection Interventions: Biological: Recombinant COVID-19 Vaccine (Sf9 Cell); Biological: COVID-19 Vaccine (Vero Cell), Inactivated Sponsors: WestVac Biopharma Co., Ltd.; West China Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials